Search Results - "Sicco, K. Lo"

Differences in the clinical presentation of bullous pemphigoid in patients with skin of colour and patients with white skin by Shah, P., Svigos, K., Yin, L., Soter, N., Lo Sicco, K., Adotama, P.

Get full text

Comparing the clinical differences in white and black women with frontal fibrosing alopecia by Adotama, P., Callender, V., Kolla, A., Young, C., Jones, P., Svigos, K., Yin, L., Ugonabo, N., Gutierrez, D., Peterson, E., Lo Sicco, K., Shapiro, J.

Get full text

Stratifying clinical response to adjuvant platelet‐rich plasma in patients with androgenetic alopecia by Juhasz, M.L.W., Sukhdeo, K., Lo Sicco, K., Shapiro, J.

Get full text

Morphoea induced by treatment with interferon beta‐1a by Peterson, E., Steuer, A., Franco, L., Nolan, M.A., Lo Sicco, K., Franks, A.G.

Get full text

Bullous id eruption in the setting of orf by Curtiss, P., Svigos, K., Chacko, M., Carey, J., Liebman, T., Lo Sicco, K.

Get full text

Low‐dose oral minoxidil increases hair density and thickness in androgenetic alopecia: a retrospective analysis of 60 patients by Yin, L., Svigos, K., Gutierrez, D., Peterson, E., Lo Sicco, K., Shapiro, J.

Get full text

Associations between clinical variables and treatment regimens and hair density and calibre in female androgenetic alopecia patients: a retrospective study of 602 patients by Tuan, H., Yin, L., Lo Sicco, K., Shapiro, J.

“…Female androgenetic alopecia (F-AGA) is characterized by hair follicle miniaturization. Its etiology is not fully understood and treatments have limited…”
Get full text

Atypical Findings in Adult-Onset Still Disease by Peterson, Erik, Krueger, L., Kim, Randie, Lo Sicco, K.

Get full text

The clinical effects of l‐arginine and asymmetric dimethylarginine: implications for treatment in secondary Raynaud's phenomenon by Curtiss, P., Schwager, Z., Lo Sicco, K., Franks, A.G.

“…Secondary Raynaud's phenomenon (RP) is often the sentinel clinical finding in systemic sclerosis and may precede systemic disease by several years. Altered…”
Get full text

Image Gallery: Treatment of refractory alopecia universalis with oral tofacitinib citrate and adjunct intralesional triamcinolone injections by Strazzulla, L.C., Avila, L., Lo Sicco, K., Shapiro, J.

Get full text

Dermatologists’ knowledge of dermoscopic features in hair and nail disorders by Kolla, A., Starace, M., Svigos, K., Yin, L., Rich, P., Gutierre, D., Krueger, L., Adotama, P., Shapiro, J., Piraccini, B., Lo Sicco, K.

Get full text

Dermatomyositis-like Chronic Graft-Versus-Host Disease With MDA5 Autoantibodies by Gutierrez, D., Krueger, L., Peterson, Erik, Franks, A. G., Sicco, K. Lo

Get full text

Frontal fibrosing alopecia in males: demographics, clinical profile and treatment experience by Peterson, E., Gutierrez, D., Brinster, N.K., Lo Sicco, K.I., Shapiro, J.

Get full text

Evaluating the contributions of dermatologists in the management of systemic sclerosis: a retrospective analysis by Rangel, L.K., Adotama, P., Shah, P., Lo Sicco, K., Femia, A.N.

“…Systemic Sclerosis (SSc) is an autoimmune condition characterized by cutaneous sclerosis and the potential for internal organ involvement. Given the…”
Get full text

Response to ‘Frontal fibrosing alopecia in men: an association with facial moisturizers and sunscreens’ by Strazzulla, L.C., Avila, L., Lo Sicco, K., Shapiro, J.

Get full text

Eczematous reaction to IVIG for the treatment of dermatomyositis by Berk-Krauss, J., Lee, K., Lo Sicco, K.I., Liebman, T.N.

“…The use of high-dose intravenous immunoglobulin (IVIG) is an accepted therapy for patients with refractory dermatomyositis. Cases of eczematous reactions to…”
Get full text

Alopecia Areata: Burden of Disease, Approach to Treatment, and Current Unmet Needs by Alhanshali, Lina, Buontempo, Michael G, Lo Sicco, Kristen I, Shapiro, Jerry

“…Alopecia areata is an autoimmune hair loss disorder with variations in distribution, duration, and severity. The disease is chronic and often follows an…”
Get full text

67 Patterns of clinical response in patients with alopecia areata (AA) treated with ritlecitinib in the ALLEGRO phase 2b/3 and ongoing, phase 3, ALLEGRO-LT studies by King, B., Mirmirani, P., Lo Sicco, K., Ramot, Y., Sinclair, R., Asfour, L., Ezzedine, K., Paul, C., Edwards, R.A., Kerkmann, U., Wajsbrot, D., Zwillich, S.H., Lejeune, A.

Get full text

LB1697 Individual SALT score trajectories of de novo patients with alopecia areata (AA) treated with ritlecitinib in the ongoing phase 3, long-term, open-label ALLEGRO-LT study by King, B., Mirmirani, P., Lo Sicco, K., Ramot, Y., Sinclair, R., Edwards, R., Kerkmann, U., Wajsbrot, D., Zwillich, S., Lejeune, A.

Get full text

1106 Successful treatment of periocular discoid lupus with cyclosporine ophthalmic emulsion (restasis) by Curtiss, P., Li, X., Lo Sicco, K., Franks, A.

Get full text